Skip to main content
Journal cover image

Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.

Publication ,  Journal Article
Lima, JJ; Castro, M; King, TS; Lang, JE; Ortega, VE; Peters, SP; Denlinger, LC; Israel, E; Sorkness, CA; Wechsler, ME; Wenzel, SE; Smith, LJ
Published in: Ann Allergy Asthma Immunol
October 2018

BACKGROUND: Use of vitamin D3 serum concentrations as a biomarker of vitamin D status is questionable because of variation in vitamin D binding protein. OBJECTIVE: To determine associations between free vitamin D3 concentrations and rates of treatment failure and exacerbations in patients with asthma participating in the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) trial. METHODS: Free concentrations were directly measured by enzyme-linked immunosorbent assay and stratified into low, medium, and high groups: less than 5pg/mL (n = 65), 5 to 9pg/mL (n = 84), and greater than 9pg/mL (n = 48) after 12 weeks of supplementation with oral vitamin D3 and associated with outcomes. RESULTS: Outcomes did not associate with free concentrations: overall treatment failure rates were 0.60 (95% confidence interval [CI] 0.46-0.78), 0.53 (95%CI 0.40- 0.70), and 0.69 (95%CI 0.54-0.90)/person-year (P = .51), respectively; overall exacerbation rates were 0.28 (95%CI 0.17-0.48), 0.15 (95%CI 0.08-0.30) and 0.42 (95%CI 0.27-0.66)/person-year (P = .22). Mean (standard deviation) baseline free concentrations were lower in non-Hispanic blacks and Hispanics compared with non-Hispanic whites: 4.10 (1.33) and 4.38 (1.11) pg/mL vs 5.16 (1.65) pg/ml, (P < .001 and P = 0.038), respectively. Mean (standard deviation) baseline free concentrations differed between females and males: 4.57 (1.58) and 5.08 (1.41) (P = .026); and between non-overweight (body mass index [BMI] < 25) and overweight (BMI > 25): 5.45 (1.86) vs 4.54 (1.39) (P < .001). The free fraction differed by race and sex but not by BMI. CONCLUSION: The use of free concentrations was inferior to total concentrations as a biomarker of efficacy of vitamin D3 supplementation in VIDA trial participants. Future studies of vitamin D status in patients with asthma should measure both free and total concentrations to better understand which marker of vitamin D function is most informative.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Allergy Asthma Immunol

DOI

EISSN

1534-4436

Publication Date

October 2018

Volume

121

Issue

4

Start / End Page

444 / 450.e1

Location

United States

Related Subject Headings

  • Vitamin D-Binding Protein
  • Vitamin D Deficiency
  • Treatment Failure
  • Sex Factors
  • Risk
  • Male
  • Humans
  • Female
  • Disease Progression
  • Dietary Supplements
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lima, J. J., Castro, M., King, T. S., Lang, J. E., Ortega, V. E., Peters, S. P., … Smith, L. J. (2018). Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial. Ann Allergy Asthma Immunol, 121(4), 444-450.e1. https://doi.org/10.1016/j.anai.2018.06.001
Lima, John J., Mario Castro, Tonya S. King, Jason E. Lang, Victor E. Ortega, Stephen P. Peters, Loren C. Denlinger, et al. “Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.Ann Allergy Asthma Immunol 121, no. 4 (October 2018): 444-450.e1. https://doi.org/10.1016/j.anai.2018.06.001.
Lima JJ, Castro M, King TS, Lang JE, Ortega VE, Peters SP, et al. Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial. Ann Allergy Asthma Immunol. 2018 Oct;121(4):444-450.e1.
Lima, John J., et al. “Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.Ann Allergy Asthma Immunol, vol. 121, no. 4, Oct. 2018, pp. 444-450.e1. Pubmed, doi:10.1016/j.anai.2018.06.001.
Lima JJ, Castro M, King TS, Lang JE, Ortega VE, Peters SP, Denlinger LC, Israel E, Sorkness CA, Wechsler ME, Wenzel SE, Smith LJ. Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial. Ann Allergy Asthma Immunol. 2018 Oct;121(4):444-450.e1.
Journal cover image

Published In

Ann Allergy Asthma Immunol

DOI

EISSN

1534-4436

Publication Date

October 2018

Volume

121

Issue

4

Start / End Page

444 / 450.e1

Location

United States

Related Subject Headings

  • Vitamin D-Binding Protein
  • Vitamin D Deficiency
  • Treatment Failure
  • Sex Factors
  • Risk
  • Male
  • Humans
  • Female
  • Disease Progression
  • Dietary Supplements